Minireviews
Copyright ©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Jan 16, 2015; 3(1): 58-64
Published online Jan 16, 2015. doi: 10.12998/wjcc.v3.i1.58
Vasopressors in obstetric anesthesia: A current perspective
Deb Sanjay Nag, Devi Prasad Samaddar, Abhishek Chatterjee, Himanshu Kumar, Ankur Dembla
Deb Sanjay Nag, Devi Prasad Samaddar, Abhishek Chatterjee, Himanshu Kumar, Ankur Dembla, Department of Anaesthesiology and Critical Care, Tata Main Hospital, Jamshedpur 831011, India
Author contributions: Nag DS and Samaddar DP conceived the concept and the structure of the review; Nag DS, Samaddar DP, Chatterjee A, Kumar H and Dembla A searched the literature and wrote the review; Nag DS and Samaddar DP edited its final manuscript.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Deb Sanjay Nag, Department of Anaesthesiology and Critical Care, Tata Main Hospital, Jamshedpur 831011, India. debsanjay@gmail.com
Telephone: +91-943-1166582 Fax: +91-657-2424031
Received: July 26, 2014
Peer-review started: July 27, 2014
First decision: August 14, 2014
Revised: August 25, 2014
Accepted: October 23, 2014
Article in press: December 23, 2014
Published online: January 16, 2015
Processing time: 172 Days and 0.9 Hours
Core Tip

Core tip: Phenylephrine has emerged as the vasopressor of choice in Obstetrics. However, the present recom-mendations are essentially based on studies conducted in elective Cesarean sections. Further studies are needed in emergency and high risk Cesarean sections in order to clarify whether there is a benefit of phenyl-ephrine over other vasopressors.